• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

10 New Drugs for Primary Care: Q3 2019

Slideshow

The third quarter saw several novel drugs win FDA-approval for a variety of conditions often seen in primary care.

Another quarter has ended, which means Patient Care® Online has compiled another list of new FDA-approved drugs for primary care and they surely did not disappoint. Numerous "firsts" were approved for various conditions ranging from asthma to type 2 diabetes to pneumonia.

Click through the slideshow below to get details on the first and only glucagon-like peptide-1 analog in pill form; the first ready-to-use injection for hypoglycemia; the first digital inhaler for asthma that connects to a mobile app; and more.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought / Image credit: ©Horacio Selva/AdobeStock

New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought

April 23rd 2024
Article

Patients with AF aged younger than 65 years have substantial comorbidity burden that may impact their future risk of mortality, reported researchers.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Treatment by Female Physicians Linked to Lower Mortality, Hospital Readmissions / image credit doctor and patient in hospital ©imtmphoto/stock.adobe.com

Treatment by Female Physicians Linked to Lower Mortality, Hospital Readmissions

April 23rd 2024
Article

Treatment by female physicians resulted in better 30-day outcomes for male and female patients, but the benefit was significantly greater for the women.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone

Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone

April 22nd 2024
Article

Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.

Vedolizumab (Entyvio) SC Approved for Maintenance Therapy in Adults with Moderately to Severely Active Crohn Disease / image credit ©SciePro/stock.adobe.com

Vedolizumab (Entyvio) SC Approved for Maintenance Therapy in Adults with Moderately to Severely Active Crohn Disease

April 22nd 2024
Article

Vedolizumab for subcutaneous injection in now indicated for maintenance therapy following IV induction in both Crohn disease and ulcerative colitis.

© 2024 MJH Life Sciences

All rights reserved.